BeStock  
Stocks › Biotechnology › ANNX

Annexon ANNX

US equityMarket cap rank #3499Biotechnology
$3.10 −$0.31 (-9.09%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.41 +10.00%
Open$3.37
Prev close$3.41
Day range$3.07 – $3.37
Volume4.46M
Market cap$591.37M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.9x
CheapRich

Below its usual level · 28th percentile, 5-year average -2.9x

Price / book5.2x
CheapRich

Near the top of its 5-year range · 97th percentile, 5-year average 2.0x

#4422 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-10x-7x-3x0xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$7.65
Price vs. fair value-59.5%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 5.23 – 1.98 97% (pricier than usual) #4422 of 5329 (1 = cheapest)
PE -3.88 -3.21 -2.90 28% (cheaper than usual) –
PS – 77.01 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ANNX.

Sign in to join the discussion.

Scroll to Top